True Greens
Natural health product licensed in Canada
- Licence holder
- Alora Naturals
- NPN or DIN-HM
- 80078275
- Status
- Active licence
- Licence date
- 9 June 2017
- Revision date
- 12 January 2026
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Medicago sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Beta vulgaris Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 1,600 mg | 400 mg | Not calculated |
| Vaccinium corymbosum Source : Fruit Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 400 mg | 100 mg | Not calculated |
| Chlorella vulgaris Source : Cellule brisée | 500 mg | Not calculated |
| Camellia sinensis Source : Feuille Extract : Matériel brut sec Extraction ratio : 40:1 Dry plant equivalent : 1,200 mg Potency : 5 % Caffeine | 30 mg | Not calculated |
| Camellia sinensis Source : Feuille Potency : 40 % Catechins | Not specified | Not calculated |
| Linum usitatissimum Source : Graine(s) | 750 mg | Not calculated |
| Prunus avium Source : Fruit Extract : Matériel brut sec Extraction ratio : 36:1 Dry plant equivalent : 7,200 mg | 200 mg | Not calculated |
| Curcuma longa Source : Rhizome Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 5,000 mg Potency : 95 % Curcuminoids | 100 mg | Not calculated |
| Extrait de pépins de raisin Source : Vitis vinifera - Graine Extract : Matériel brut sec Extraction ratio : 30:1 Dry plant equivalent : 900 mg Potency : 90 % Proanthocyanidins | 30 mg | Not calculated |
| Ginkgo biloba Source : Feuille Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 1,500 mg Potency : 24 % Flavonoid glycosides | 30 mg | Not calculated |
| Taraxacum officinale Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 400 mg | 100 mg | Not calculated |
| Silybum marianum Source : Fruit Potency : 80 % Silymarin | 100 mg | Not calculated |
| Sambucus nigra subsp. nigra Source : Fruit Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 240 mg | 60 mg | Not calculated |
| Schisandra chinensis Source : Fruit Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 800 mg Potency : 2 % Schisandrins | 200 mg | Not calculated |
| Lepidium meyenii Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 2,000 mg | 500 mg | Not calculated |
| Palmaria palmata Source : En entier | 400 mg | Not calculated |
| Withania somnifera Source : Racine Potency : 2 % Withanolides | 125 mg | Not calculated |
| Eleutherococcus senticosus Source : Racine Potency : 0.8 % Eleutherosides | 80 mg | Not calculated |
| Panax ginseng Source : Racine Potency : 10 % Total ginsenosides | 50 mg | Not calculated |
| Lactobacillus rhamnosus Source : Cellule entière | 5 Milliards d'UFC | Not calculated |
| Inuline Source : Cichorium intybus - racine | 1,000 mg | Not calculated |
| Avena sativa Source : Fibre de graine | 500 mg | Not calculated |
| Pectine Source : Malus domestica - Fruit | 500 mg | Not calculated |
| Medicago sativa Source : Sommité | 500 mg | Not calculated |
| Vaccinium myrtillus Source : Fruit Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 120 mg | 30 mg | Not calculated |
| Punica granatum Source : Seed aril Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 240 mg Potency : 40 % Ellagic acid | 60 mg | Not calculated |
| Arthrospira platensis Source : En entier | 1,500 mg | Not calculated |
| Vaccinium macrocarpon Source : Fruit Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 400 mg | 100 mg | Not calculated |
| Hordeum vulgare Source : Feuille | 500 mg | Not calculated |
| Triticum aestivum Source : Feuille | 500 mg | Not calculated |
| Avena sativa Source : Feuille | 500 mg | Not calculated |
| Petroselinum crispum Source : Sommité | 250 mg | Not calculated |
| Brassica oleracea var. viridis Source : Feuille | 250 mg | Not calculated |
| Euterpe oleracea Source : Fruit Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 600 mg | 150 mg | Not calculated |
| Malpighia glabra Source : Fruit Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 800 mg | 200 mg | Not calculated |
| Brassica oleracea var. italica Source : Sommité Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 400 mg | 100 mg | Not calculated |
| Lycopène Source : Solanum lycopersicum - Chair (fruit) | 3 mg | Not calculated |
| Lutéine Source : Tagetes erecta - Fleur | 5 mg | Not calculated |
| trans-Resvératrol Source : Reynoutria Japonica - racine | 10 mg | Not calculated |
| Astragalus membranaceus Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 400 mg | 100 mg | Not calculated |
Non-medicinal ingredients
Erythritol, Saveur, Acide citrique, Extrait de feuilles de stévia
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Mesures | 1 Tous les jours |
Uses authorised in Canada
Source of/Provides antioxidants. Source of/Provides antioxidants that help fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Provides antioxidants for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy can occur, in which case discontinue use and consult your healthcare practitioner. Some people may experience insomnia, anxiety, or headaches, in which case, discontinue use. Diuretic effect may occur. Stop use and seed medical attention immediately if you experience dizziness, confusion, muscle weakness or pain, abnormal heart beat and/or difficulty breathing. Rare, unpredictable cases of liver injury associated with green tea extract-containing products have been reported (in Canada and internationally).
- Contre-indications
Do not use if you have high blood pressure. Do not use if you are pregnant. Do not use if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase the risk of spontaneous bleeding. Do not use if you have heart disease, low blood pressure, kidney or liver disorder, diabetes or edema (swelling of hands, face and feet) or are taking products containing diuretics. Do not use if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment).
- Précautions et mises en garde
If you are breastfeeding, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you are undergoing hormone replacement therapy (HRT) or taking birth control medication. If you are taking blood thinners or digoxin, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you have a history of kidney stones. Consult a health care practitioner prior to use if you have gallstones or a bile duct obstruction. Consult a health care practitioner prior to use if you are taking medications for seizures. If you have liver or gall bladder diseases, and/or intestinal obstruction, consult a health care practitioner prior to use. If you are taking antidepressants, consult a health care practitioner prior to use. Consumption with alcohol, other drugs or natural health products with sedative properties is not recommended. Consult a health care practitioner prior to use if you have any type of acute infection. If you have a liver disorder, consult a health care practitioner prior to use. Stop use if you develop symptoms of liver trouble such as yellowing of the skin/eyes (jaundice), stomach pain, dark urine, sweating, nausea, unusual tiredness and/or loss of appetite and consult a health care practitioner. Consult a health care practitioner prior to use if you have iron deficiency. Discontinue use and consult a health care practitioner in case of gastrointestinal upsets, such as abdominal cramps, nausea, vomiting, diarrhea. Consult a health care practitioner prior to use if you have fever, vomiting, bloody diarrhea, or severe abdominal pain.
Source
Official Health Canada record, licence 80078275
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.